EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C26H38N2O4S5 |
| Net Charge | 0 |
| Average Mass | 602.935 |
| Monoisotopic Mass | 602.14351 |
| SMILES | COc1c(SC)c(CCN(C)C)c2sc3c(OC)c(OC)c(SC)c(CCN(C)C)c3ssc2c1OC |
| InChI | InChI=1S/C26H38N2O4S5/c1-27(2)13-11-15-21(33-9)18(30-6)20(32-8)26-23(15)35-25-19(31-7)17(29-5)22(34-10)16(12-14-28(3)4)24(25)36-37-26/h11-14H2,1-10H3 |
| InChIKey | MGWYCLOYGLKCFF-UHFFFAOYSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Lissoclinum badium (ncbitaxon:322848) | - | PubMed (17268087) |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | marine metabolite Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. animal metabolite Any eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lissoclibadin 2 (CHEBI:66580) has role animal metabolite (CHEBI:75767) |
| lissoclibadin 2 (CHEBI:66580) has role antineoplastic agent (CHEBI:35610) |
| lissoclibadin 2 (CHEBI:66580) has role marine metabolite (CHEBI:76507) |
| lissoclibadin 2 (CHEBI:66580) is a aromatic ether (CHEBI:35618) |
| lissoclibadin 2 (CHEBI:66580) is a aryl sulfide (CHEBI:35683) |
| lissoclibadin 2 (CHEBI:66580) is a organic heterotricyclic compound (CHEBI:26979) |
| lissoclibadin 2 (CHEBI:66580) is a organosulfur heterocyclic compound (CHEBI:38106) |
| lissoclibadin 2 (CHEBI:66580) is a tertiary amino compound (CHEBI:50996) |
| IUPAC Name |
|---|
| 2,2'-[3,4,9,10-tetramethoxy-2,8-bis(methylsulfanyl)dibenzo[c,f][1,2,5]trithiepine-1,7-diyl]bis(N,N-dimethylethanamine) |
| Registry Numbers | Sources |
|---|---|
| Reaxys:10130382 | Reaxys |
| Citations |
|---|